Idiopathic Pulmonary Fibrosis (IPF) Research Solutions

Watch our video to learn how our digital solutions and clinical science expertise can support the development of better IPF treatments and therapeutic options by helping to:

• Mitigate variability and inconsistencies from clinician-reported outcome assessments
• Simplify the electronic completion of patient-reported outcome assessments
• Reduce participation and travel burdens by facilitating virtual study visits
• Streamline the consent and reconsent processes